Accessibility Menu
Nippon Shinyaku logo

Nippon Shinyaku(OTC) NPPNY

Market Cap$1.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)-52%
5 Year-67%
1 Year+20%
1 Month+2%
$6.11
+1.83%
+0.11Today
Nippon Shinyaku last closing stock price
MetricPriceDate
Last closeUSD 6.112026-07-30
Nippon Shinyaku stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.83%USD 6.002026-07-23
1 month+1.83%USD 6.002026-06-30
3 month-25.03%USD 8.152026-04-30
Year to date-31.88%USD 8.972025-12-31
1 year+19.55%USD 5.112025-07-30
3 year-35.22%USD 9.432023-07-31
5 year-66.72%USD 18.362021-07-22
Since inception-51.51%USD 12.602016-11-16

Nippon Shinyaku Financials at a Glance

Market Cap

$1.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥173.13B

Net Income (TTM)

¥30.10B

EPS (TTM)

$0.73

P/E Ratio

8.31

Dividend

$0.20

Beta (Volatility)

0.01 (Low)

Price

$6.11

Volume

5

Open

$6.11

Previous Close

$6.11

Daily Range

$6.11 - $6.11

52-Week Range

$5.03 - $15.21

Estimated Earnings Date

Aug 8, 2024

NPPNY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nippon Shinyaku

Nippon Shinyaku Co., Ltd. is a prominent pharmaceutical company based in Kyoto, Japan, specializing in the development and sale of innovative drugs and functional food products. Established in 1911, the company operates in various therapeutic areas, including urology, hematology, and rare diseases, while also focusing on health food ingredients and supplements.

Products and Services
  • Pharmaceuticals for urology, hematology, and rare diseases
  • Health food ingredients, preservatives, and protein preparations
  • Clinical development partnerships for innovative therapies
Growth Outlook
  • Strong pipeline with ongoing clinical trials for novel therapies
  • Expansion into international markets to enhance revenue streams
  • Focus on R&D to drive innovation and product development
Financial Highlights
  • Recent quarterly revenue of 44.4 billion JPY, showcasing robust sales
  • Trailing twelve months (TTM) net income margin of 17.4%, indicating profitability
  • Low debt ratio of 0.007, reflecting strong financial stability
Nippon Shinyaku Co., Ltd. has demonstrated a commitment to innovation and growth within the pharmaceutical sector. The company's diverse product offerings and strategic partnerships position it well for future expansion. Recent financial performance highlights a solid revenue base and profitability, supported by a low debt profile, which enhances its financial resilience. The ongoing focus on research and development, coupled with a strong pipeline of clinical trials, suggests a promising outlook for potential investors.
AI Generated • Jul 31, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2,309

Website

www.nippon-shinyaku.co.jp

Headquarters

Kyoto, KY 601-8550, JP

NPPNY Financials

Key Financial Metrics (TTM)

Gross Margin

66.35%

Operating Margin

19.34%

Net Income Margin

17.40%

Return on Equity

10.94%

Return on Capital

11.86%

Return on Assets

8.58%

Earnings Yield

12.03%

Dividend Yield

3.20%

Payout Ratio

28.11%

Stock Overview

Market Cap

$1.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

269.60M

Volume

5

Avg. Volume

82.175

Financials (TTM)

Gross Profit

¥114.86B

Operating Income

¥32.81B

EBITDA

¥40.51B

Operating Cash Flow

¥20.85B

Capital Expenditure

-¥2.12B

Free Cash Flow

¥18.73B

Cash & ST Invst.

¥76.92B

Total Debt

¥2.58B

Nippon Shinyaku Performance Analysis

Nippon Shinyaku annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 1,064,313,887-13.1%
20242024-03-31JPY 1,026,601,246-3.5%
20252025-03-31JPY 1,051,043,7162.4%
20262026-03-31JPY 1,133,244,6567.8%
Nippon Shinyaku sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-301.6%
Q22025-09-303.2%
Q32025-12-3118.5%
Q42026-03-31-8.1%
Nippon Shinyaku annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.63-24.3%
20242024-03-31JPY 0.666.3%
20252025-03-31JPY 0.7919.3%
20262026-03-31JPY 0.73-7.7%
Nippon Shinyaku sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-30106.1%
Q22025-09-30-7.0%
Q32025-12-3132.1%
Q42026-03-31-61.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

¥44.44B

+14.2%

Gross Profit

¥28.70B

+7.9%

Gross Margin

64.60%

N/A

Market Cap

$1.65BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$713.42K

N/A

Employees

2,309

N/A

Net Income

¥3.95B

-1.5%

EBITDA

¥4.47B

+6.6%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

¥76.92B

+39.3%

Total Debt

¥2.58B

-5.3%

Accounts Receivable

¥46.36B

+9.6%

Inventory

¥51.82B

+21.9%

Long Term Debt

¥1.66B

+20.9%

Short Term Debt

¥916.96M

-32.0%

Return on Assets

8.58%

N/A

Return on Invested Capital

10.86%

N/A

Free Cash Flow

¥15.16B

-18.1%

Operating Cash Flow

¥15.77B

-17.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GTBIFGreen Thumb Industries Inc.
$7.10+1.28%
TCNNFTrulieve Cannabis Corp.
$8.10-2.76%
CMOPFCosmo Pharmaceuticals N.V.
$74.00-1.40%
EVOTFEvotec SE
$6.69+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About NPPNY

What is the current price of Nippon Shinyaku?

Nippon Shinyaku is trading at $6.11 per share.

What is the 52-week range for Nippon Shinyaku?

Over the past 52 weeks, Nippon Shinyaku has traded between $5.03 and $15.21.

How much debt does Nippon Shinyaku have?

As of the most recent reporting period, Nippon Shinyaku reported total debt of ¥16.14M.

How much cash does Nippon Shinyaku have on hand?

Nippon Shinyaku reported ¥429.27M in cash and cash equivalents in its most recent financial results.

What is Nippon Shinyaku’s dividend yield?

Nippon Shinyaku currently has a dividend yield of 3.20%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services